Investor R&D Day 2022

Welcome to Investor R&D Day 2022

January 28, 2022

Agenda and webcast replay


Deb Hart
Senior Director
Investor Relations

Carl Hull
Chief Executive Officer

Doreen Pippen
Vice President Marketing

Dr. Mike Mitchell
Skirkanich Assistant Professor of Innovation
Bioengineering, Mitchell Lab, University of Pennsylvania

Dr. Mohamad-Gabriel Alameh
Director of Engineered mRNA and Targeted Nanomedicine Core Weissman Lab, Univeristy of Pennsylvania

Christine Dolan
Chief Operating Officer
Biologics Safety Testing

Eric Biship
Vice President, R&D
Cygnus Technologies®

David Cetlin
Senior Director, R&D
Cygnus Technologies®

Brian Neel
Chief Operating Officer
Nucleic Acid Production

Michael Houston
Chief Scientific Officer
TriLink BioTechnologies®

Kevin Herde
Executive Vice President and Chief Financial Officer


Supporting documents